vs

Side-by-side financial comparison of Apollo Commercial Real Estate Finance, Inc. (ARI) and CODEXIS, INC. (CDXS). Click either name above to swap in a different company.

Apollo Commercial Real Estate Finance, Inc. is the larger business by last-quarter revenue ($73.3M vs $38.9M, roughly 1.9× CODEXIS, INC.). Apollo Commercial Real Estate Finance, Inc. runs the higher net margin — 39.9% vs 24.7%, a 15.2% gap on every dollar of revenue. On growth, CODEXIS, INC. posted the faster year-over-year revenue change (81.3% vs 4.0%). Over the past eight quarters, CODEXIS, INC.'s revenue compounded faster (51.0% CAGR vs -4.6%).

Apollo Commercial Real Estate Finance, Inc. is a real estate investment trust that originates, acquires and manages commercial real estate debt assets including mortgages, mezzanine loans and mortgage-backed securities, primarily operating in the U.S. market to deliver consistent risk-adjusted returns.

Codexis, Inc. is a protein engineering company that develops enzymes for pharmaceutical, food and medical applications.

ARI vs CDXS — Head-to-Head

Bigger by revenue
ARI
ARI
1.9× larger
ARI
$73.3M
$38.9M
CDXS
Growing faster (revenue YoY)
CDXS
CDXS
+77.4% gap
CDXS
81.3%
4.0%
ARI
Higher net margin
ARI
ARI
15.2% more per $
ARI
39.9%
24.7%
CDXS
Faster 2-yr revenue CAGR
CDXS
CDXS
Annualised
CDXS
51.0%
-4.6%
ARI

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ARI
ARI
CDXS
CDXS
Revenue
$73.3M
$38.9M
Net Profit
$29.2M
$9.6M
Gross Margin
94.8%
Operating Margin
39.7%
27.1%
Net Margin
39.9%
24.7%
Revenue YoY
4.0%
81.3%
Net Profit YoY
-28.2%
192.5%
EPS (diluted)
$0.19
$0.13

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ARI
ARI
CDXS
CDXS
Q4 25
$73.3M
$38.9M
Q3 25
$61.6M
$8.6M
Q2 25
$70.9M
$15.3M
Q1 25
$65.8M
$7.5M
Q4 24
$70.5M
$21.5M
Q3 24
$71.6M
$12.8M
Q2 24
$81.1M
$8.0M
Q1 24
$80.5M
$17.1M
Net Profit
ARI
ARI
CDXS
CDXS
Q4 25
$29.2M
$9.6M
Q3 25
$50.8M
$-19.6M
Q2 25
$20.7M
$-13.3M
Q1 25
$26.0M
$-20.7M
Q4 24
$40.7M
$-10.4M
Q3 24
$-91.5M
$-20.6M
Q2 24
$35.8M
$-22.8M
Q1 24
$-104.5M
$-11.5M
Gross Margin
ARI
ARI
CDXS
CDXS
Q4 25
94.8%
Q3 25
71.3%
Q2 25
86.3%
Q1 25
63.8%
Q4 24
83.0%
Q3 24
66.4%
Q2 24
56.6%
Q1 24
71.6%
Operating Margin
ARI
ARI
CDXS
CDXS
Q4 25
39.7%
27.1%
Q3 25
82.8%
-220.3%
Q2 25
29.4%
-83.9%
Q1 25
39.7%
-271.6%
Q4 24
57.9%
-34.2%
Q3 24
-127.8%
-129.0%
Q2 24
44.2%
-284.9%
Q1 24
-129.6%
-69.6%
Net Margin
ARI
ARI
CDXS
CDXS
Q4 25
39.9%
24.7%
Q3 25
82.4%
-228.1%
Q2 25
29.3%
-86.6%
Q1 25
39.5%
-274.3%
Q4 24
57.7%
-48.4%
Q3 24
-127.9%
-160.8%
Q2 24
44.1%
-285.2%
Q1 24
-129.8%
-67.4%
EPS (diluted)
ARI
ARI
CDXS
CDXS
Q4 25
$0.19
$0.13
Q3 25
$0.34
$-0.22
Q2 25
$0.12
$-0.16
Q1 25
$0.16
$-0.25
Q4 24
$0.25
$-0.12
Q3 24
$-0.69
$-0.29
Q2 24
$0.23
$-0.32
Q1 24
$-0.76
$-0.16

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ARI
ARI
CDXS
CDXS
Cash + ST InvestmentsLiquidity on hand
$139.8M
$78.2M
Total DebtLower is stronger
$40.1M
Stockholders' EquityBook value
$1.9B
$50.5M
Total Assets
$9.9B
$147.8M
Debt / EquityLower = less leverage
0.79×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ARI
ARI
CDXS
CDXS
Q4 25
$139.8M
$78.2M
Q3 25
$245.9M
$58.7M
Q2 25
$177.6M
$66.3M
Q1 25
$166.4M
$59.8M
Q4 24
$317.4M
$73.5M
Q3 24
$194.3M
$90.3M
Q2 24
$174.7M
$73.2M
Q1 24
$161.2M
$85.5M
Total Debt
ARI
ARI
CDXS
CDXS
Q4 25
$40.1M
Q3 25
$39.7M
Q2 25
$39.4M
Q1 25
$29.2M
Q4 24
$28.9M
Q3 24
$28.6M
Q2 24
$28.4M
Q1 24
$28.1M
Stockholders' Equity
ARI
ARI
CDXS
CDXS
Q4 25
$1.9B
$50.5M
Q3 25
$1.9B
$38.5M
Q2 25
$1.8B
$55.6M
Q1 25
$1.9B
$49.6M
Q4 24
$1.9B
$66.9M
Q3 24
$1.9B
$73.4M
Q2 24
$2.0B
$61.4M
Q1 24
$2.0B
$79.3M
Total Assets
ARI
ARI
CDXS
CDXS
Q4 25
$9.9B
$147.8M
Q3 25
$9.5B
$124.0M
Q2 25
$9.8B
$138.2M
Q1 25
$8.8B
$128.9M
Q4 24
$8.4B
$149.0M
Q3 24
$9.1B
$148.2M
Q2 24
$9.3B
$132.0M
Q1 24
$9.2B
$149.6M
Debt / Equity
ARI
ARI
CDXS
CDXS
Q4 25
0.79×
Q3 25
1.03×
Q2 25
0.71×
Q1 25
0.59×
Q4 24
0.43×
Q3 24
0.39×
Q2 24
0.46×
Q1 24
0.35×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ARI
ARI
CDXS
CDXS
Operating Cash FlowLast quarter
$142.5M
$20.1M
Free Cash FlowOCF − Capex
$19.6M
FCF MarginFCF / Revenue
50.3%
Capex IntensityCapex / Revenue
1.3%
Cash ConversionOCF / Net Profit
4.88×
2.09×
TTM Free Cash FlowTrailing 4 quarters
$-23.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ARI
ARI
CDXS
CDXS
Q4 25
$142.5M
$20.1M
Q3 25
$31.7M
$-7.7M
Q2 25
$63.2M
$-18.0M
Q1 25
$39.3M
$-13.8M
Q4 24
$200.3M
$-16.5M
Q3 24
$47.2M
$-13.0M
Q2 24
$50.2M
$-12.2M
Q1 24
$52.8M
$-7.8M
Free Cash Flow
ARI
ARI
CDXS
CDXS
Q4 25
$19.6M
Q3 25
$-7.9M
Q2 25
$-20.5M
Q1 25
$-15.1M
Q4 24
$-18.2M
Q3 24
$-14.0M
Q2 24
$-12.6M
Q1 24
$-8.9M
FCF Margin
ARI
ARI
CDXS
CDXS
Q4 25
50.3%
Q3 25
-91.7%
Q2 25
-133.6%
Q1 25
-199.6%
Q4 24
-85.0%
Q3 24
-109.0%
Q2 24
-157.5%
Q1 24
-52.2%
Capex Intensity
ARI
ARI
CDXS
CDXS
Q4 25
1.3%
Q3 25
2.1%
Q2 25
16.4%
Q1 25
16.7%
Q4 24
8.3%
Q3 24
7.8%
Q2 24
5.0%
Q1 24
6.6%
Cash Conversion
ARI
ARI
CDXS
CDXS
Q4 25
4.88×
2.09×
Q3 25
0.62×
Q2 25
3.05×
Q1 25
1.51×
Q4 24
4.93×
Q3 24
Q2 24
1.40×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons